Citius Pharmaceuticals Inc. Common

Citius Pharmaceuticals, Inc. - Unlocking Potential. Faster.

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class ...

Citius Pharmaceuticals, Inc. (CTXR) - Yahoo Finance

Net Income Avi to Common (ttm). --. Diluted EPS (ttm). --. Balance Sheet and Cash Flow. Total Cash (mrq). --. Total Debt/Equity (mrq). --.

Citius Pharmaceuticals, Inc. Common Stock (CTXR) - Nasdaq

Discover real-time Citius Pharmaceuticals, Inc. Common Stock (CTXR) stock prices, quotes, historical data, news, and Insights for informed trading and ...

Citius Pharmaceuticals Inc. Stock Quote (U.S. - CTXR - MarketWatch

CTXR | Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Citius Pharmaceuticals Announces $3 Million Registered Direct ...

Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the ... common stock and accompanying warrants to purchase up to an ...

Citius Pharmaceuticals Inc (CTXR) Stock Price & News - Google

Elite Pharmaceuticals, Inc. Common Stock. $0.58. ELTP ; Marinus Pharmaceuticals Inc. $0.30. MRNS ; BioLine RX Ltd - ADR. $0.45. BLRX ; Northwest Biotherapeutics ...

Citius Pharmaceuticals Raises $3M in Direct Offering at ... - Stock Titan

Citius Pharmaceuticals Inc. Common. NASDAQ:CTXR. CTXR Rankings. #4744 Ranked by Market Cap · N/A Ranked by Dividends. CTXR Latest News. Nov 11 ...

CTXR - Citius Pharmaceuticals, Inc. (NasdaqCM) - Share Price and ...

The Factor Analysis chart (below right) shows a view of Citius Pharmaceuticals, Inc. from a variety of lenses. Each factor shows how well the company ranks ...

Citius Pharmaceuticals Inc. Common - CTXR STOCK NEWS

Citius Pharmaceuticals Inc. (Nasdaq: CTXR) is a specialty biopharmaceutical company dedicated to the development and commercialization of first-in-class ...

Investors - Stock Information - Citius Pharmaceuticals, Inc.

Nasdaq: CTXR ; Price. $0.33. Volume ; Change. -0.00. % Change ; Today's Open. $0.32. Previous Close ; Intraday High. $0.33. Intraday Low ; 52 Week High. $1.07. 52 ...

Citius Pharmaceuticals, Inc. Common Stock (CTXR) Earnings

Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment ...

r/CTXR - Reddit

Citius Pharmaceuticals Inc. (Nasdaq: CTXR. ) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and ...

Investor FAQs - Citius Pharmaceuticals

The Company acquired all of the outstanding stock of LMB by issuing shares of its common stock. ... Citius Pharmaceuticals, Inc. 11 Commerce Drive, First ...

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 ...

PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma ... As of June 30, 2024, the Company had 158,857,798 common shares outstanding.

CTXR: Citius Pharmaceuticals Inc - Stock Price, Quote and News

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. It develops and commercializes critical care products with a focus on oncology.

Citius Pharmaceuticals, Inc. 2020 Omnibus Stock Incentive Plan.

Pursuant to the Company's bylaws the vote of a majority of shares of common stock either present in person or represented by proxy and entitled to vote will be ...

CTXR | Citius Pharmaceuticals Inc. Stock Overview (U.S. - Barron's

Complete Citius Pharmaceuticals Inc. stock information by Barron's. View real-time CTXR stock price and news, along with industry-best analysis.

Citius Pharmaceuticals Announces TenX Keane Shareholder ...

PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...

Citius Pharmaceuticals, Inc. Stock (CTXR) - Quote Nasdaq

Citius Pharmaceuticals, Inc. (CTXR.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Citius Pharmaceuticals, ...

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial ...

As of September 30, 2023, the Company had 158,857,798 common shares outstanding. The Company estimates that its available cash resources ...